BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bailly C, Vergoten G. Proposed mechanisms for the extracellular release of PD-L1 by the anticancer saponin platycodin D. Int Immunopharmacol 2020;85:106675. [PMID: 32531711 DOI: 10.1016/j.intimp.2020.106675] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Shah D, Ajazuddin, Bhattacharya S. Role of natural P-gp inhibitor in the effective delivery for chemotherapeutic agents. J Cancer Res Clin Oncol 2023;149:367-91. [PMID: 36269390 DOI: 10.1007/s00432-022-04387-2] [Reference Citation Analysis]
2 Deng B, Sun M. Platycodin D inhibits the malignant progression of papillary thyroid carcinoma by NF-κB and enhances the therapeutic efficacy of pembrolizumab. Drug Dev Res 2021. [PMID: 34859901 DOI: 10.1002/ddr.21902] [Reference Citation Analysis]
3 Zhou Y, Farooqi AA, Xu B. Comprehensive review on signaling pathways of dietary saponins in cancer cells suppression. Crit Rev Food Sci Nutr 2021;:1-26. [PMID: 34751072 DOI: 10.1080/10408398.2021.2000933] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Ri MH, Ma J, Jin X. Development of natural products for anti-PD-1/PD-L1 immunotherapy against cancer. J Ethnopharmacol 2021;281:114370. [PMID: 34214644 DOI: 10.1016/j.jep.2021.114370] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
5 Zaynab M, Sharif Y, Abbas S, Afzal MZ, Qasim M, Khalofah A, Ansari MJ, Khan KA, Tao L, Li S. Saponin toxicity as key player in plant defense against pathogens. Toxicon 2021;193:21-7. [PMID: 33508310 DOI: 10.1016/j.toxicon.2021.01.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
6 Xiao S, Liu N, Yang X, Ji G, Li M. Polygalacin D suppresses esophageal squamous cell carcinoma growth and metastasis through regulating miR-142-5p/Nrf2 axis. Free Radic Biol Med 2021;164:58-75. [PMID: 33307164 DOI: 10.1016/j.freeradbiomed.2020.11.029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
7 Bailly C, Vergoten G. Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome? Pharmacol Ther. 2020;214:107618. [PMID: 32592716 DOI: 10.1016/j.pharmthera.2020.107618] [Cited by in Crossref: 136] [Cited by in F6Publishing: 144] [Article Influence: 45.3] [Reference Citation Analysis]